2021
DOI: 10.1111/1440-1681.13466
|View full text |Cite
|
Sign up to set email alerts
|

The potential value of dequalinium chloride in the treatment of cancer: Focus on malignant glioma

Abstract: Dequalinium chloride has been known as one kind of antibiotic that displays a broad antimicrobial spectrum and has been clinically proven to be very safe. In recent years, studies have shown that dequalinium chloride can inhibit the growth of malignant tumours, and reports were mainly used for solid tumours. Glioblastoma is the most common malignant neuroepithelial tumour of the central nervous system in adults, and the prognosis of glioblastoma is poor as it has a high resistance to apoptosis. This review sum… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
11
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8
1

Relationship

4
5

Authors

Journals

citations
Cited by 18 publications
(11 citation statements)
references
References 109 publications
0
11
0
Order By: Relevance
“…From a total of 17 compounds, 7 were cytotoxic (IC 50 <200 µM), inhibiting PC‐3, LNCaP, and MatLyLu cell viability, and the most active compound 10 was also active against nontumor prostate cells, benign hyperplastic prostatic epithelial cells (BPH‐1); however, it showed a more specific response to tumor cells than dequalinium, a drug used as a reference. [ 33,34 ] The results are summarized in Table 2.…”
Section: Resultsmentioning
confidence: 99%
“…From a total of 17 compounds, 7 were cytotoxic (IC 50 <200 µM), inhibiting PC‐3, LNCaP, and MatLyLu cell viability, and the most active compound 10 was also active against nontumor prostate cells, benign hyperplastic prostatic epithelial cells (BPH‐1); however, it showed a more specific response to tumor cells than dequalinium, a drug used as a reference. [ 33,34 ] The results are summarized in Table 2.…”
Section: Resultsmentioning
confidence: 99%
“…Glioblastoma multiforme (GBM) is the most common and most aggressive malignant tumor of the central nervous system in adults ( Pan et al, 2021b ). Nowadays, in the treatment of GBM, the technique of resection, radiation therapy, and chemotherapeutic drugs have made progress, but survival has not been significantly prolonged ( Yu et al, 2020 ).…”
Section: Introductionmentioning
confidence: 99%
“…Low grade gliomas (LGG), including WHO grade II and III, are common primary tumors in the CNS, accounting for approximately 20-29% of primary CNS tumors [8,9]. LGG has the potential to evolve into glioblastoma (GBM), but LGG is less aggressive than GBM, with a median survival time of more than 7 years, unlike GBM, which has a 5-year survival rate of 4-5% [9,10]. The main treatment method for LGG remains surgical resection, but surgery does not completely stop the recurrence of LGG due to the presence of glioma stem cells and immune cell in ltration of the tumor microenvironment (TME) [11,12].…”
Section: Introductionmentioning
confidence: 99%